Oct 5 (Reuters) - Sunesis Pharmaceuticals Inc : * Roth Capital raises Sunesis Pharmaceuticals Inc price target to $12 from $7; rating buy For a summary of rating and price target changes on U.S. companies: Reuters Eikon users, click on Reuters 3000Xtra users, double-click Reuters Station users, click .1568 For a summary of rating and price target changes on Canadian companies: Reuters Eikon users, click on Reuters 3000Xtra users, double-click Reuters Station users, click .4899 ((Bangalore Newsroom +91 80 4135 5800; within U.S. +1 646 223 8780))